返回 
加入收藏
取消药品价格管制对药品价格的影响研究
x
请在关注微信后，向客服人员索取文件
| 篇名： | 取消药品价格管制对药品价格的影响研究 |
| TITLE： | Study on the Effects of the Deregulation of Drug Price Control on Drug Price |
| 摘要： | 目的：研究取消药品价格管制对药品价格的影响，为相关政策的制订提供依据。方法：提取全国医药经济信息网数据库中2012年1月－2017年6月788家样本医院46875个化学药品和生物制品价格（通过固定拉氏价格指数衡量）的季度数据，通过间断时间序列模型，分析政府取消限价管制和加强价格监测（涉及2014年《关于印发做好常用低价药品供应保障工作意见的通知》、2015年《关于印发推进药品价格改革意见的通知》等政策），回归市场竞争后化学药品和生物制品总体价格，以及细分为低价药品、原研药及仿制药品亚组的价格变化情况，提出取消药品价格管制对药品价格的影响。结果与结论：在取消常用低价药品的最高零售限价后，低价药品价格有较大幅度增长[斜率变化量（β3）＝1.11×10－2，P＝0.008]；全面取消药品价格管制后，化学药品和生物制品总体价格（β3＝－1.85×10－3，P＝0.175）和各亚组药品价格均无明显变化（低价药：β3＝1.10×10－3，P＝0.066；原研药：β3＝－7.20×10－4，P＝0.549；仿制药：β3＝6.78×10－4，P＝0.784）。2015年取消药品定价政策实施后的2年内，药品价格及药品市场依然保持稳定，可见对成熟市场取消政府定价、放开价格管制，使价格的形成回归市场，再结合政府加强价格监测的做法是可行的。 |
| ABSTRACT： | OBJECTIVE：To study the effects of the deregulation of drug price control on drug price ，and to provide reference for policy formulation. METHODS ：The quarterly price data of 46 875 chemical and biological products （measured by fixed Laspeyres index ）were collected from 788 sample hospitals from the database of National Medical Economic Information Network during Jan. 2012 to Jun. 2017. Based on the interrupted time series model ，changes in the prices of overall situation of chemicals and biological products ，as well as the sub-group ，ie. low-cost drugs ，original and imitated drugs were analyzed after the government’s policies of canceling the price limit control and strengthening the price monitoring （including Notice on Printing and Distributing the Opinions on the Supply and Guarantee of Commonly Used Low-cost Drugs in 2014，Notice on Printing and Distributing the Opinions on Promoting the Reform of Drug Prices in 2015，etc.），returning to market competition ；the effects of canceling the price limit control on drug price were put forward. RESULTS & CONCLUSIONS ：After government deregulation for maximum retail price limit of commonly used low-priced drugs ，the price of low-priced drugs increased substantially （β3＝1.11×10－2， P＝0.008）. After the total abolition of drug price control ，there was no significant change in the overall chemical and biological products（β3＝－1.85×10－3，P＝0.175）and sub-group （low-cost drugs ：β3＝1.10×10－3，P＝0.066；original drugs ：β3＝－7.20×10－4， P＝0.549；generic drugs ：β3＝6.78×10－4，P＝0.784）drug prices. Within two years after government deregulation policy in 2015， drug prices and the drug market had remained stable. It can be seen that it is feasible for canceling the government ’s pricing and opening the price control in the mature market so as to make the price formulation return to the market ，combined with the government strengthening the price monitoring. |
| 期刊： | 2020年第31卷第03期 |
| 作者： | 汪偌宁，韩晟，樊迪，史录文，陈敬 |
| AUTHORS： | WANG Ruoning ，HAN Sheng，FAN Di，SHI Luwen ，CHEN Jing |
| 关键字： | 政府管制；取消管制；药品价格；市场；化学药品和生物制品 |
| KEYWORDS： | Government regulation ；Deregulation；Drug price ；Market；Chemical and biological product |
| 阅读数： | 671 次 |
| 本月下载数： | 12 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
